SEC Form 4 · accession 0001703619-17-000001
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Atul Kavthekar
Officer — Chief Financial Officer
Period of report
Nov 20, 2017
Accepted (ET)
Nov 20, 2017 · 10:57 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2017 | P | 2,000 | $15.00 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.